December 5, 2018 Project combines highly sensitive biomarker discovery with human stem cell technology to develop a much needed blood diagnostic assay for Parkinson’s disease By Benjamin Boettner
In The News
David Walt and George Church receive grant from Chan Zuckerberg Initiative to enable better diagnosis and monitoring of Parkinson’s disease
FierceBiotech | November 19, 2018
by Conor Hale
PharmaVOICE | November 16, 2018
Contributed by: Denise Myshko
Thrive Global | November 12, 2018
This Sunday was Veterans Day, a time to honor those who have selflessly served our country. While our veterans are front and center on this day, they have been missing from a critical conversation over the past couple of years. By Kevin Hrusovsky
GenomeWeb | November 08, 2018
Nov 07, 2018 | Adam Bonislawski
GenomeWeb | November 07, 2018
NEW YORK (GenomeWeb) – Expedeon said today it has signed a supply and license agreement with Quanterix to provide that company non-exclusive access to its immunoassay offerings.
GenomeWeb | November 01, 2018
NEW YORK (GenomeWeb) – Quanterix reported after the close of the market on Thursday that its third quarter revenues rose 85 percent year-over-year, thanks largely to an 82 percent increase in quarterly product revenues.
Multiple Sclerosis News Today | October 12, 2018
By Jose Marques Lopez, PhD
Enjoyed discussing the future of cancer care and the role biomarkers will play in advancing less invasive detection options, more accurate diagnoses and more personalized treatment pathways with PharmaVOICE.